Vaccination induced antibodies to recombinant avian influenza a virus M2 protein or synthetic M2e peptide do not bind to the M2 protein on the virus or virus infected cells.

BACKGROUND: Influenza viruses are characterized by their highly variable surface proteins HA and NA. The third surface protein M2 is a nearly invariant protein in all Influenza A strains. Despite extensive studies in other animal models, this study is the first to describe the use of recombinant M2 protein and a peptide coding for the extracellular part of the M2 protein (M2e) to vaccinate poultry. METHODS: Four groups of layer chickens received a prime-boost vaccination with recombinant M2 protein, M2e, a tetrameric construct from M2e peptide bound to streptavidin and a control tetrameric construct formulated with Stimune adjuvant. RESULTS: We determined the M2-specific antibody (Ab) responses in the serum before vaccination, three weeks after vaccination and two weeks after booster, at days 21, 42 and 56 of age. The group vaccinated with the M2 protein in combination with Stimune adjuvant showed a significant Ab response to the complete M2 protein as compared to the other groups. In addition an increased Ab response to M2e peptide was found in the group vaccinated with the M2e tetrameric construct. None of the vaccinated animals showed seroconversion to AI in a commercial ELISA. Finally no Ab’s were found that bound to M2 expressed on in vitro AI infected MDCK cells. CONCLUSION: Although Ab’s are formed against the M2 protein and to Streptavidin bound M2e peptide in a tetrameric conformation these Ab’s do not recognize of M2 on the virus or on infected cells

Development of cross-protective Eimeria-vectored vaccines based on apical membrane antigens

Recently, the availability of protocols supporting genetic complementation of Eimeria has raised the prospect of generating transgenic parasite lines which can function as vaccine vectors, expressing and delivering heterologous proteins. Complementation with sequences encoding immunoprotective antigens from other Eimeria spp. offers an opportunity to reduce the complexity of species/strains in anticoccidial vaccines. Herein, we characterise and evaluate EtAMA1 and EtAMA2, two members of the apical membrane antigen (AMA) family of parasite surface proteins from Eimeria tenella. Both proteins are stage-regulated, and the sporozoite-specific EtAMA1 is effective at inducing partial protection against homologous challenge with E. tenella when used as a recombinant protein vaccine, whereas the merozoite-specific EtAMA2 is not. In order to test the ability of transgenic parasites to confer heterologous protection, E. tenella parasites were complemented with EmAMA1, the sporozoite-specific orthologue of EtAMA1 from E. maxima, coupled with different delivery signals to modify its trafficking and improve antigen exposure to the host immune system. Vaccination of chickens using these transgenic parasites conferred partial protection against E. maxima challenge, with levels of efficacy comparable to those obtained using recombinant protein or DNA vaccines. In the present work we provide evidence for the first known time of the ability of transgenic Eimeria to induce cross protection against different Eimeria spp. Genetically complemented Eimeria provide a powerful tool to streamline the complex multi-valent anticoccidial vaccine formulations that are currently available in the market by generating parasite lines expressing vaccine targets from multiple eimerian species

Genomic markers associated with antibody response to Newcastle disease virus of Sasso chickens raised in Ethiopia

Newcastle disease virus (NDV) is one of the highly contagious avian pathogens that threatens poultry producers in endemic zones due to its epidemic potential. Selection for antibody (Ab) response can effectively improve disease resistance in chickens. However, the molecular basis of the variation in Ab response to NDV is unclear. This study aimed to detect genomic markers and genes modulating Ab response to NDV in chickens reared under tropical, outdoor conditions. A genome-wide association study (GWAS) was conducted on Sasso T451A chickens that were naturally exposed to infectious diseases from 56 to 112 days of age to identify regions associated with Ab response to NDV. Phenotypic immune data from 935 chickens, monitored in two batches, and genotyping data of these chickens based low-pass sequencing (2,676,181 single nucleotide polymorphisms, SNPs) were used. BioMart data mining and variant effect predictor tools were used to annotate SNPs and candidate genes, respectively. A total of five SNPs (rs316795557 (FOXP2), chr 1; rs313761644 (CEP170B), chr 5; rs733628728, chr 13; and two unnamed SNPs, chr 30 and chr 33) were associated with the chicken antibody response to NDV at the suggestive significance level. These SNPs are located on chromosomes 1, 5, and 13 and are in genomic regions that contain several genes with roles in the regulation of the immune response. The results of this study pave the path for more investigation into the host immune response of chickens to NDV.</p

Infectious Bronchitis Virus induces acute interferon-gamma production through polyclonal stimulation of chicken leukocytes

AbstractInfectious Bronchitis Virus, a member of the Coronaviridae, is a respiratory pathogen in poultry. We found that in vitro stimulation with IBV resulted in ChIFN-γ production in splenocytes of both infected birds and uninfected birds. The non-specific stimulation did not occur when other avian viruses or other coronaviruses were used or when mammalian cells were stimulated with IBV. Inactivation of IBV reduced ChIFN-γ production, but ChIFN-γ remained elevated compared to unstimulated cells. An increase in ChIFN-γ mRNA was detected in splenocytes from IBV-infected and uninfected chickens as early as 1 h after stimulation with IBV. These results indicate that IBV acts as a polyclonal stimulus, inducing a rapid production of IFN-γ even without previous exposure to the virus